Cleveland Clinic Breast Cancer Update: Review of Breast Cancer Symposia 2025
A focused Cleveland Clinic breast cancer update designed to translate major 2025 breast cancer symposium findings into practical clinical strategies across high-risk screening, imaging, surgery, hormone receptor-positive disease, triple-negative breast cancer, HER2-positive disease, radiation oncology, biomarkers, predictive models, prognostic tools, and survivorship care.
Course Details:
Cleveland Clinic Breast Cancer Update: Review of Breast Cancer Symposia 2025 includes 8 recorded video sessions and 1 PDF agenda/resource, offering a concise one-day review of clinically important breast cancer updates from major oncology meetings.
Focus: High-risk screening, advanced imaging modalities, surgical updates, hormone receptor-positive breast cancer, triple-negative breast cancer, HER2-positive breast cancer, radiation oncology updates, biomarkers, predictive and prognostic models, survivorship care, multidisciplinary treatment planning, clinical implications of new evidence, and practical breast cancer case discussions.
About This Course
Breast cancer care continues to evolve rapidly, with new evidence influencing screening, imaging, surgery, systemic therapy, radiation oncology, biomarker interpretation, risk prediction, and survivorship planning.
Cleveland Clinic Breast Cancer Update: Review of Breast Cancer Symposia 2025 distills important findings from leading breast cancer conferences into clinically actionable insights for oncology teams. The course emphasizes how new data can be applied in real-world multidisciplinary breast cancer care.
The program is designed for medical oncologists, radiation oncologists, surgical oncologists, breast surgeons, oncology nurses, nurse practitioners, physician assistants, fellows, residents, women’s health professionals, and breast care team members seeking a practical update in modern breast cancer management.
Why Choose This Course
- Cleveland Clinic 2025 breast cancer update in a focused recorded format
- Includes 8 video sessions and 1 PDF agenda/resource
- Summarizes clinically relevant highlights from major breast cancer symposia
- Covers the full spectrum of care: screening, imaging, surgery, systemic therapy, radiation, biomarkers, and survivorship
- Includes subtype-specific treatment updates for HR-positive, HER2-positive, and triple-negative breast cancer
- Reviews biomarker-driven treatment planning, predictive models, and prognostic tools
- Designed for multidisciplinary breast cancer care teams and oncology trainees
- Concise format for busy clinicians who want practical, practice-ready breast cancer updates
Core Learning Areas
Screening & Imaging
High-risk screening, imaging modalities, diagnostic work-up, risk prediction, early detection strategies, and patient selection for advanced breast imaging.
Surgery & Radiation
Surgical management updates, breast surgery decision-making, plastic surgery considerations, radiation techniques, and evolving local-regional therapy strategies.
Systemic Therapy
HR-positive breast cancer, HER2-positive biologic therapies, triple-negative breast cancer strategies, treatment sequencing, and emerging therapeutic options.
Biomarkers & Survivorship
Biomarker-driven planning, predictive and prognostic models, survivorship care models, long-term follow-up, quality of life, and multidisciplinary care pathways.
Complete Curriculum
- One-day Cleveland Clinic breast cancer update in recorded format
- Review of key data from major breast cancer symposia
- Clinical implications of newly presented breast cancer research
- Multidisciplinary learning across oncology, surgery, radiation, imaging, and survivorship
- Practical focus on translating evidence into patient care
- Case-based and panel-style clinical discussion
- High-yield update for breast cancer care teams
- Diagnostic work-up of breast cancer
- High-risk screening strategies
- Advanced breast imaging modalities
- Risk prediction frameworks for breast cancer screening
- Patient selection for intensified surveillance
- Clinical implications of imaging findings
- Integrating screening and imaging into multidisciplinary breast care
- Current updates in breast cancer surgery
- Oncologic surgery approaches to breast cancer
- Plastic surgery considerations in breast cancer care
- Local therapy decision-making
- Surgical planning based on tumor biology and patient factors
- Multidisciplinary coordination with medical and radiation oncology
- Practical surgical updates for breast cancer treatment pathways
- Current standards in HR-positive breast cancer treatment
- Endocrine therapy strategies and treatment sequencing
- Biomarker selection in HR-positive disease
- Adjuvant and metastatic treatment considerations
- Risk stratification and recurrence prevention
- Emerging evidence from major breast cancer meetings
- Clinical decision-making for individualized HR-positive breast cancer care
- Current strategies in triple-negative breast cancer
- Systemic treatment options for TNBC
- Biomarker-driven treatment planning
- Immunotherapy and emerging biologic therapy considerations
- Early-stage and metastatic TNBC management updates
- Clinical implications of recent symposium data
- Practical decision-making in aggressive breast cancer subtypes
- Biology of HER2-positive breast cancer
- Current HER2-positive treatment standards
- Biologic therapy updates in HER2-positive disease
- Antibody-based and targeted treatment strategies
- Treatment sequencing across disease stages
- Clinical interpretation of new HER2-positive trial data
- Practical management of HER2-positive breast cancer patients
- Updated approaches for radiation in breast cancer treatment
- Radiation techniques and clinical indications
- Local-regional control considerations
- Integration of radiation therapy with surgery and systemic therapy
- Patient selection for radiation strategies
- Symposium highlights affecting radiation oncology practice
- Practical multidisciplinary coordination for radiation treatment planning
- Biomarker-driven treatment planning in breast cancer
- Predictive models for treatment selection
- Prognostic tools for risk assessment
- Use of biomarkers across HR-positive, HER2-positive, and triple-negative breast cancer
- Clinical interpretation of molecular and biologic data
- How models influence treatment escalation or de-escalation
- Practical integration of biomarker data into patient care decisions
- Breast cancer survivorship care models
- Long-term follow-up after breast cancer treatment
- Quality of life considerations in survivorship
- Monitoring for recurrence and treatment-related effects
- Coordination between oncology, primary care, and women’s health teams
- Patient-centered survivorship planning
- Practical strategies for improving long-term breast cancer outcomes
- Coordination between medical oncology, radiation oncology, surgery, imaging, and survivorship teams
- Translating research findings into institutional protocols
- Case-based treatment planning across disease subtypes
- Balancing evidence, patient preference, toxicity, and disease risk
- Clinical discussion of evolving care standards
- Decision-making tools for breast cancer teams
- Improving patient outcomes through team-based oncology care
- Condensed insights from leading breast cancer conferences
- Focus on clinical implications of new information
- How to interpret new data for patient management
- Applying symposium findings to treatment pathways
- Supporting immediate clinical decision-making
- Expert-led case discussion and panel-style learning
- Efficient update format for busy breast cancer professionals
Learning Objectives
- Discuss diagnostic work-up strategies for breast cancer
- Review high-risk screening approaches and advanced imaging modalities
- Summarize oncologic and plastic surgery approaches to breast cancer
- Describe current approaches for radiation therapy in breast cancer treatment
- Identify systemic treatment options for hormone receptor-positive breast cancer
- Review current and emerging strategies for triple-negative breast cancer
- Explain biology and treatment considerations in HER2-positive breast cancer
- Apply biomarker, predictive model, and prognostic model data to treatment planning
- Translate major breast cancer symposium findings into clinical practice
- Improve multidisciplinary care planning across diagnosis, treatment, prevention, and survivorship
Who Should Take This Course
This course is designed for medical oncologists, radiation oncologists, surgical oncologists, breast surgeons, nurses, nurse practitioners, physician assistants, residents, fellows, women’s health professionals, and other healthcare providers involved in the care of patients with breast cancer.
It is especially useful for clinicians and teams who manage breast cancer screening, diagnostic work-up, surgery, systemic therapy, radiation treatment, biomarker-driven decision-making, survivorship planning, and multidisciplinary breast program protocols.
Delivery & Access
8 Videos
Recorded breast cancer update sessions covering screening, surgery, systemic therapy, radiation, biomarkers, and survivorship.
1 PDF
Agenda/resource PDF included for organized review and reference.
2.32 GB
Complete recorded course package with video and PDF learning materials.
Support
Course Highlights
Symposium-to-Clinic Update
Condenses major breast cancer symposium findings into practical clinical insights for oncology teams.
Subtype-Specific Therapy
Dedicated coverage of HR-positive, HER2-positive, and triple-negative breast cancer treatment strategies.
Multidisciplinary Care
Covers screening, imaging, surgery, radiation, biomarkers, predictive models, prognostic tools, and survivorship.
FAQ
Who is this course best suited for?
This course is best suited for medical oncologists, radiation oncologists, surgical oncologists, breast surgeons, nurses, nurse practitioners, physician assistants, residents, fellows, women’s health professionals, and breast cancer care teams.
What is included in this course?
The course includes 8 recorded video sessions and 1 PDF agenda/resource, with a total package size of 2.32 GB.
What topics are covered?
Topics include high-risk screening, imaging modalities, surgical updates, hormone receptor-positive breast cancer, triple-negative breast cancer, HER2-positive breast cancer, radiation oncology, biomarkers, predictive and prognostic models, and survivorship care.
Does this course cover triple-negative breast cancer?
Yes. The course includes a dedicated session on triple-negative breast cancer strategies, along with sessions on HR-positive and HER2-positive breast cancer.
Does this course cover biomarkers?
Yes. The course includes biomarkers, predictive models, prognostic models, and biomarker-driven treatment planning.
Is this course focused on clinical practice?
Yes. The course is designed to translate breast cancer symposium findings into clinically actionable strategies for multidisciplinary breast cancer care.
Is this a recorded course?
Yes. This product is provided as recorded course access so you can review the material at your own pace.
Does this course include CME or a certificate?
No. CME credits and certificates are not included with this course package.
Who can I contact for support?
You can contact support at [email protected].
Reviews
There are no reviews yet.